Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21884099 | 0.80 | GABRA1 (0.43) | GABRA1GABRB2 | |
| SCHEMBL10799329 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2 | |
| SCHEMBL11807767 | 0.77 | GABRA1 (0.46) | GABRA1GABRB2 | |
| SCHEMBL15788771 | 0.69 | TSHR (0.44) | GABRA1GABRB2 | |
| SCHEMBL4886989 | 0.68 | LMNA (0.46) | — | |
| SCHEMBL24456198 | 0.67 | ALOX15 (0.59) | GABRA1GABRB2 | |
| SCHEMBL10545243 | 0.67 | POLB (0.38) | GABRA1GABRB2 | |
| SCHEMBL903950 | 0.67 | GABRA1 (0.37) | GABRA1GABRB2 | |
| SCHEMBL16736693 | 0.65 | ALOX15 (0.47) | — | |
| SCHEMBL273226 | 0.65 | ALDH1A1 (0.38) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-1817318-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | Nippon Shokubai Co.,Ltd. (JP) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006080538-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | AR, AHR, BCL6 | GABRA1 2034/4885GABRB2 2521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.